Acquisition Opportunity Attune Medical was acquired by Haemonetics for 160M in March 2024, signaling a strategic expansion and potential cross-sell opportunities for Haemonetics’ broader customer base in cardiac and blood management, as well as access to larger distribution channels.

Regulatory Leadership Recent hire of Melinda Smith as VP of Regulatory Affairs strengthens global regulatory strategy, creating openings for selling additional regulatory and quality support services or enhanced compliance solutions to medical device customers seeking streamlined approvals in multiple regions.

Integrated Temperature Care EnsoETM offers a user-friendly, closed-loop temperature management system compatible with existing heat exchangers, presenting upsell potential for hospitals investing in comfort, safety, and efficiency with compatible hardware and consumables.

Distribution Expansion Non-exclusive distribution agreement with Gentherm to provide Blanketrol III heat exchangers to ensoETM users broadens the product ecosystem and creates co-sell opportunities with a broader customer base and potential bundle offers.

Growth Readiness Revenue is in the low seven figures with substantial growth momentum implied by ongoing funding history and a Series C in 2018, suggesting readiness for strategic partnerships, channel investments, and international expansions to accelerate market penetration.